Download PDF

Canadian Journal of Anaesthesia

, Volume 45, Supplement 1, pp R117–R137 | Cite as

Intravenous Infusion Techniques: how to do it and why we should do it

  • Peter S. A. Glass
Article

Keywords

Fentanyl Remifentanil Sufentanil Alfentanil Volatile Anaesthetic 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Techniques de perfusion intraveineuse: comment procéder et pourquoi

Download to read the full article text

References

  1. 1.
    Alvis JM, Reves JG, Govier AV, et al. Computer assisted continuous infusions of fentanyl during cardiac anaesthesia: comparison with a manual method. Anesthesiology 1985; 63: 419.CrossRefGoogle Scholar
  2. 2.
    Glass PSA, Shafer SL, Jacobs JR, Reves JG. Intravenous drug delivery systems. In: Miller R (Ed.). Anaesthesia, 4th ed. New York, NY: Churchill Livingstone, 1994: 389–416.Google Scholar
  3. 3.
    Ausems ME, Vuyk J, Hug CC, Stanski DR. Comparison of a computer-assisted infusion versus intermittent bolus administration of alfentanil as a supplement to nitrous oxide for lower abdominal surgery. Anesthesiology 1988; 68: 851–61.PubMedGoogle Scholar
  4. 4.
    Reves J, Glass PSA, Jacobs J. Midazolam and alfentanil: new anaesthetic drugs for continuous infusion and an automated method of administration. Mt. Sinai J Med 1989; 56: 99.PubMedGoogle Scholar
  5. 5.
    White PF. Use of continuous infusion versus intermittent bolus administration of fentanyl or ketamine during outpatient anaesthesia. Anesthesiology 1983; 59: 294.PubMedGoogle Scholar
  6. 6.
    White PF, Dworsky WA, Horai Y, Trevor AJ. Comparison of continuous infusion fentanyl or ketamine versus thiopental-determining the mean effective serum concentrations for outpatient surgery. Anesthesiology 1983; 59: 564.PubMedGoogle Scholar
  7. 7.
    Shafer SL, Varvel JR. Pharmacokinetics, pharmacodynamics, and rational opioid selection. Anesthesiology 1991; 74: 53–63.PubMedGoogle Scholar
  8. 8.
    Scott JC, Ponganis KV, Stanski DR. EEG quantitation of narcotic effect: The comparative pharmacodynamics of fentanyl and alfentanil. Anesthesiology 1985; 62: 234–41.PubMedCrossRefGoogle Scholar
  9. 9.
    Sheiner LB, Stanski DR, Vozeh S, Miller RD, Ham J. Simultaneous modelling of pharmacokinetics and pharmacodynamics: application to d-tubocurarine. Clin Pharm Ther 1979; 25: 358–71.Google Scholar
  10. 10.
    Vinik HR, Bradley Jr EL, Kissin I. Triple anaesthetic combination:propofol-midazolamalfentanil. Anesth Analg 1994; 78: 354–8.PubMedGoogle Scholar
  11. 11.
    Schwilden H, Schuttler J, Stoekel H. Pharmacokinetics as applied to total intravenous anaesthesia: theoretical considerations. Anaesthesia 1983; 38: 51–2.PubMedGoogle Scholar
  12. 12.
    Roberts FL, Dixon J, Lewis GTR, Tackley RM, Prys-Roberts C. Induction and maintenance of propofol anaesthesia. A manual infusion scheme. Anaesthesia 1988; 43(Suppl): 14–7.PubMedCrossRefGoogle Scholar
  13. 13.
    Hughes MA, Glass PSA, Jacobs JR. Context-sensitive half-time in multicompartment pharmacokinetic models for intravenous anaesthetic drugs. Anesthesiology 1992; 76: 334–41.PubMedCrossRefGoogle Scholar
  14. 14.
    Ausems ME, Hug CC Jr, Stanski DR, Burm AGL. Plasma concentrations of alfentanil required to supplement nitrous oxide anaesthesia for general surgery. Anesthesiology 1986; 65: 362–73.PubMedCrossRefGoogle Scholar
  15. 15.
    Meyer HH. Theorie der Alkoholnarkose. Arch Exp Pathol Pharmakol 1899; 42: 109–18.CrossRefGoogle Scholar
  16. 16.
    Overton E. Studien uber die Narkose Zugleich ein Beitrag zur Allgemeinen Pharmakologie. Jena, Germany 1901; Verlag von Gustav Fischer.Google Scholar
  17. 17.
    Quasha AL, Eger EI, Tinker JH. Determination and applications of MAC. Anesthesiology 1980; 53: 315–34.PubMedCrossRefGoogle Scholar
  18. 18.
    Koblin DD, Chortkoff BS, Laster MJ, et al. Polyhalogenated and perflorinated compounds that disobey the Meyer-Overton hypothesis. Anesth Analg 1994; 79: 1043–8.PubMedCrossRefGoogle Scholar
  19. 19.
    Franks NP, Lieb WR. Molecular and cellular mechanisms of general anaesthesia. Nature 1994; 367: 807–14.CrossRefGoogle Scholar
  20. 20.
    Tanelian DL, Kosek P, Mody I, Mclver MB. The role of the GABAA receptor/chloride channel complex in anaesthesia. Anesthesiology 1993; 78: 757–76.PubMedCrossRefGoogle Scholar
  21. 21.
    Rampil IJ, Mason P. Singh H. Anaesthetic potency (MAC) is independent of forebrain structures in the rat. Anesthesiology 1993; 78: 707–12.PubMedCrossRefGoogle Scholar
  22. 22.
    Rampil IJ. Anaesthetic potency (MAC) is not altered after hypothermic spinal cord transection in rats. Anesthesiology 1994; 80: 606–10.PubMedCrossRefGoogle Scholar
  23. 23.
    Antognini JF, Schwartz K. Exaggerated anaesthetic requirements in the preferentially anesthetized brain. Anesthesiology 1993; 79: 1244–9.PubMedGoogle Scholar
  24. 24.
    Murphy MR, Hug CC. The anaesthetic potency of fentanyl in terms of its reduction of enflurane MAC. Anesthesiology 1982; 57: 485–8.PubMedCrossRefGoogle Scholar
  25. 25.
    McEwan Al, Smith C, Dyar O, Goodman D, Glass PSA. Isoflurane MAC reduction by fentanyl. Anesthesiology 1993; 78: 864–9.PubMedCrossRefGoogle Scholar
  26. 26.
    Brunner MD, Braithwaite P, Jhaveri R, et al. The MAC reduction of isoflurane by sufentanil. Br J Anaesth 1994; 72: 42–6.PubMedCrossRefGoogle Scholar
  27. 27.
    Lang E, Kapila A, et al. The reduction of the MAC of isoflurane by remifentanil. Anesthesiology 1996; 85: 721–8.PubMedCrossRefGoogle Scholar
  28. 28.
    Westmoreland C, Sebel PS, Groper A, Hug CC Jr. Reduction of isoflurane MAC by fentanyl or alfentanil. Anesthesiology 1992; 77: A394.CrossRefGoogle Scholar
  29. 29.
    Sebel PS, Glass PSA, Fletcher JE, Murphy MR, Gallagher C, Quill T. Reduction of the MAC of desflurane with fentanyl. Anesthesiology 1992; 76: 52–9.PubMedCrossRefGoogle Scholar
  30. 30.
    Smith C, McEwan Al, Jhaveri R, et al. The interaction of fentanyl on the Cp50 of propofol for loss of consciousness and skin incision. Anesthesiology 1994; 81: 820–8.PubMedCrossRefGoogle Scholar
  31. 31.
    Vuyk J, Lim T, Engbers FHM, Burm AGL, Vletter AA, Bovill JG. The pharmacodynamic interaction of propofol and alfentanil during lower abdominal surgery in female patients. Anesthesiology 1995; 83: 8–22.PubMedCrossRefGoogle Scholar
  32. 32.
    Glass PSA, Bloom M, Kearse L, Rosow C, Sebel PPM. Bispectral analysis measures sedation and memory effects of propofol, midazolam, isoflurane, and alfentanil in healthy volunteers. Anesthesiology 1997; 86: 836–47.PubMedCrossRefGoogle Scholar
  33. 33.
    Lui J, Singh H, White PF. Electroencephalographm bispectral analysis predicts the depth of midazolamindiced sedation. Anesthesiology 1996; 84: 64–9.CrossRefGoogle Scholar
  34. 34.
    Gan TJ, Glass PS, Windsor A, et al. BIS utility Study Group, Bispectral index monitoring allows faster emergence and improved recovery from propofol, alfentanil, and nitrous oxide anaesthesia. Anesthesiology 1997; 87: 808–15.PubMedCrossRefGoogle Scholar
  35. 35.
    Song D, Joshi GP, White PF. Titration of volatile anaesthetics using bispectral index facilitates recovery after ambulatory anaesthesia. Anesthesiology 1997; 87: 842–8.PubMedCrossRefGoogle Scholar

Copyright information

© Canadian Anesthesiologists 1998

Authors and Affiliations

  • Peter S. A. Glass
    • 1
  1. 1.Department of AnesthesiaDuke University Medical CenterDurhamUSA

Personalised recommendations